Estimated Risk Reduction for Clinical Outcomes After SGLT-2i Initiation

Estimated Risk Reduction for Clinical Outcomes Given the Observed eGFR Decine After Starting SGLT-2i. The dataset is a 5.5 KB XLS file authored by Ransmond O. Berchie and shared under a CC-BY-4.0 license on figshare. It was last updated on April 29, 2026.

Use Cases

• Estimate clinical risk reduction based on observed eGFR decline mentioned in the description
• Analyze the relationship between SGLT-2 inhibitor initiation and kidney function metrics
• Model potential patient outcomes following changes in estimated glomerular filtration rate

Strengths

• Dataset is openly licensed under CC-BY-4.0, permitting broad reuse.
• File size is 5.5 KB, indicating a focused and likely manageable dataset.

Limitations

• Row count is unknown, which may limit suitability assessment.
• Column-level documentation is absent; field semantics must be inferred after download.
• Description metadata is limited; actual data quality requires manual inspection after download.

Provenance

Source

figshare

Freshness

Last updated 2026-04-29 17:47:01; freshness should be verified.